Altered fibrin clot properties are associated with residual vein obstruction: Effects of lipoprotein(a) and apolipoprotein(a) isoform

Thrombosis Research

Volumn 130, Issue 3, 2012, Pages

  Undas, Anetta ^a,b   Cieśla Dul, Mariola ^b   Dra̧zkiewicz, Tomasz ^b   Sadowski, Jerzy ^a,b  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

Author keywords

Coagulation; Fibrin clot; Fibrinolysis; Lipoprotein(a); Venous thrombosis

Indexed keywords

APOLIPOPROTEIN A; D DIMER; HEPARIN; LIPOPROTEIN A; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; FIBRIN CLOT; FIBRINOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESIDUAL VEIN OBSTRUCTION; THROMBOPHILIA; TURBIDIMETRY; VEIN OCCLUSION;

ADULT; AGED; APOPROTEIN(A); FEMALE; FIBRIN CLOT LYSIS TIME; FIBRINOGEN; HUMANS; LIPOPROTEIN(A); MALE; MIDDLE AGED; PROTEIN ISOFORMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; VENOUS THROMBOSIS;

EID: 84865277310     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.06.005     Document Type: Article

References (25)

1. P. Prandoni, A.W. Lensing, M.H. Prins, E. Bernardi, A. Marchiori, and P. Bagatella Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism Ann Intern Med 137 2002 955 960
2. L. Young, P. Ockelford, D. Milne, V. Rolfe-Vyson, S. McKelvie, and P. Harper Post-treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality J Thromb Haemost 4 2006 1919 1924
3. M. Galli, W. Ageno, A. Squizzato, F. Dentali, E. Manfredi, and L. Steidl Residual venous obstruction in patients with a single episode of deep vein thrombosis and in patients with recurrent deep vein thrombosis Thromb Haemost 94 2005 93 95
4. L. Spiezia, D. Tormene, R. Pesavento, L. Salmaso, P. Simioni, and P. Prandoni Thrombophilia as a predictor of persistent residual vein thrombosis Haematologica 93 2008 479 480
5. A. Undas, and R.A.S. Ariens Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases Arterioscler Thromb Vasc Biol 31 2011 e88 e99
6. A. Undas Acquired dysfibrinogenemia in atherosclerotic vascular disease Pol Arch Med Wewn 121 2011 110 119
7. A. Undas, K. Zawilska, M. Ciesla-Dul, A. Lehmann-Kopydłowska, A. Skubiszak, and K. Ciepłuch Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives Blood 114 2009 4272 4278
8. T. Lisman, P.G. de Groot, J.C.M. Meijers, and F.R. Rosendaal Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis Blood 105 2005 1102 1105
9. M.E. Meltzer, T. Lisman, P.G. de Groot, J.C. Meijers, S. le Cessie, and C.J. Doggen Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1 Blood 116 2010 113 121
10. A. Undas, E. Stepien, W. Tracz, and A. Szczeklik Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis J Thromb Haemost 4 2006 973 975
11. S.M. Marcovina, J.J. Albers, E. Wijsman, Z. Zhang, N.H. Chapman, and H. Kennedy Differences in Lp(a) concentrations and apo(a) polymorphs between black and white Americans J Lipid Res 37 1996 2569 2585
12. M.C. Cheung, J.J. Albers, H. Kennedy, H. Deguchi, D.J. Elias, and P.M. Averell Association of Apo(a) isoform size with dyslipoproteinemia in male venous thrombosis patients Clin Chim Acta 411 2010 1279 1283
13. P. Prandoni, M.H. Prins, A.W. Lensing, A. Ghirarduzzi, W. Ageno, and D. Imberti Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial Ann Intern Med 150 2009 577 585
14. B. Cosmi, C. Legnani, A. Iorio, V. Pengo, A. Ghirarduzzi, and S. Testa Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the PROLONG study Eur J Vasc Endovasc Surg 39 2010 356 365
15. M. Carrier, M. Rodger, P.S. Wells, and M. Righini Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep-vein thrombosis: a systematic review and meta-analysis J Thromb Haemost 9 2011 1119 1125
16. P.A. Kyrle, F.R. Rosendaal, and S. Eichinger Risk assessment for recurrent venous thrombosis Lancet 376 2010 2032 2039
17. S. Siragusa, A. Malato, G. Saccullo, A. Iorio, M. Di Ianni, and C. Caracciolo Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study Am J Hematol 86 2011 914 917
18. M. von Depka, U. Nowak-Göttl, R. Eisert, C. Dieterich, M. Barthels, and I. Scharrer Increased lipoprotein (a) levels as an independent risk factor for venous thromboembolism Blood 96 2000 3364 3368
19. R. Vormittag, T. Vukovich, M. Stain, S. Lehr, E. Minar, and I. Pabinger Lipoprotein (a) in patients with spontaneous venous thromboembolism Thromb Res 120 2007 15 20
20. D. Rouy, P. Grailhe, F. Nigon, J. Chapman, and E. Angles-Cano Lipoprotein(a) impairs generation of plasmin by fibrin-bound tissue-type plasminogen activator. In vitro studies in a plasma milieu Arterioscler Thromb 11 1991 629 638
21. N.T. Feric, M.B. Boffa, S.M. Johnston, and M.L. Koschinsky Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen: a novel mechanism for lipoprotein(a)-mediated inhibition of plasminogen activation J Thromb Haemost 6 2008 2113 2120
22. L. Hervio, M.J. Chapman, J. Thillet, S. Loyau, and E. Angles-Cano Does apolipoprotein(a) heterogeneity influence lipoprotein(a) effects on fibrinolysis? Blood 82 1993 392 397
23. S. Erqou, A. Thompson, E. Di Angelantonio, D. Saleheen, S. Kaptoge, and S. Marcovina Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants J Am Coll Cardiol 55 2010 2160 2167
24. P. Prandoni Links between arterial and venous disease J Intern Med 262 2007 341 350
25. H.G. Kraft, A. Lingenhel, S. Kochl, F. Hoppichler, F. Kronenberg, and A. Abe Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease Arterioscler Thromb Vasc Biol 16 1996 713 719